Mintr Compass
$115.02
ABT · Abbott Laboratories
54 Neutral · Mid Horizon
54Neutral
Price Action51
Business Quality40
Market Confidence78
AI READ as of 2026-08-20
Trading Neutral
  • Recent news coverage remains mostly positive
  • Price momentum is currently showing signs of improvement
  • The stock is showing relative strength compared to its peers
Investing Weak
  • The company faces challenges regarding its overall business quality
  • Current company growth and valuation metrics appear unfavorable
  • The broader healthcare sector faces significant ongoing headwinds
Price & Momentum · Trading
Technical
36
Rel. Strength
65
Momentum
68
Proximity
33
Sentiment
79
Business & Value · Investing
Quality
38
Balance Sheet
46
Growth
37
Valuation
39
Analyst
78
Open ABT in Compass →
Ratings current as of 2026-08-19. Algorithmic percentile rankings from historical and delayed data — not investment advice or a recommendation to buy or sell any security. Markets involve risk including loss of principal. Methodology · Terms · Privacy